• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number ESBF2814C103E
Device Problems Leak/Splash (1354); Device Damaged by Another Device (2915)
Patient Problem Insufficient Information (4580)
Event Date 11/06/2023
Event Type  Injury  
Event Description
Heli-fx endoanchors were implanted in an endurant iis graft esbf2814c103.During the endovascular treatment of an abdominal aortic ane urysm.It was noted that the patient had a high torque and tortuous anatomy with a short, angled neck.The endoanchors were being implanted prophylactically due to the patients hostile aortic neck it was reported that during the index procedure, when implanting the 5 endoachor, the enoanchor's position was reviewed at stage 1 and the physician was happy to proceed.At stage stage 2 when deploying the endoachor the endoachor began deploying then popped rolling sideways.It was suspected that the broken endoachor lifted the stent graft causing a type ia endoleak.Once the type ia endoleak was noted, 4 additional endoanchors were added to try to correct the issue and 2-3 endoranchors can be seen around the broken anchor.The endoachor was suspected to be securely stuck between the grafts and vessel wall.The other broken part of the endoanchor was successfully removed from the patient.Per the physician the cause of the endoanchor fracture and type ia endoleak is undetermined.However, the patient¿s anatomy was tortuous with a very hostile neck, and the broken endoanchor may have lifted the graft causing a type ia endoleak.No additional clinical sequelae were reported, and the patient will be monitored.
 
Manufacturer Narrative
Film evaluation summary: the reported fractured endoanchor and type ia endoleak were confirmed on the films provided, but the cause of these events could not be determined.Full procedural angiograms showing attempts to deploy the endoanchor were not received for a thorough analysis of the event.Pre-implant ct¿s were not available for review and a comprehensive assessment of the patient¿s anatomy could not be performed.Possible anatomical causes of the anchor fracture include implanting into areas of calcification, thrombus, and highly angulated anatomy.In addition, improper apposition, excessive catheter torque build-up, engaging multiple fabric layers, and excessive unsupported applier can contribute to an endoanchor fracture.It is possible the type ia endoleak was caused by the fractured endoanchor lifting the graft fabric as what was reported, but this could not be confirmed.The reported short and angulated aortic neck could also have contributed to the type ia endoleak.Analysis of the returned images did not reveal any out of specification stent graft integrity issues.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18275005
MDR Text Key329840200
Report Number9612164-2023-05808
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberESBF2814C103E
Device Catalogue NumberESBF2814C103E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/06/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/21/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/21/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age70 YR
Patient SexFemale
-
-